Researchers developed SAMP-Score, a machine learning tool that uses cell image morphology to screen for compounds inducing senescence in p16-positive cancer cells.
Key Details
- 1SAMP-Score leverages high-content microscopy images and morphological profiles (SAMPs) to classify cell senescence.
- 2The system screened over 10,000 compounds in p16-positive basal-like breast cancer (BLBC) cells.
- 3It identified QM5928 as a compound that consistently induced cancer cell senescence without killing normal cells.
- 4QM5928 was effective even in cancers resistant to drugs like palbociclib, which are often problematic in high p16-expressing cancers.
- 5The study demonstrates SAMP-Score's ability to detect nuanced morphological changes via AI analysis.
- 6SAMP-Score is openly available to the research community on GitHub.
Why It Matters
This study highlights how AI-driven image analysis can identify promising new drug candidates by detecting subtle cellular changes that traditional methods might miss. Such advances could accelerate development of therapies, particularly for cancers that lack clear biomarkers and respond poorly to existing treatments.
Source
EurekAlert
Related News
•EurekAlert
MD Anderson Unveils New AI Genomics Insights and Therapeutic Advances
MD Anderson reports breakthroughs in cancer therapeutics and provides critical insights into AI models for genomic analysis.
•EurekAlert
UCLA Researchers Present AI, Blood Biomarker Advances at SABCS 2025
UCLA Health researchers unveil major advances in breast cancer AI pathology, liquid biopsy, and biomarker strategies at the 2025 SABCS.
•EurekAlert
SH17 Dataset Boosts AI Detection of PPE for Worker Safety
University of Windsor researchers released SH17, a 8,099-image open dataset for AI-driven detection of personal protective equipment (PPE) in manufacturing settings.